Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

IMpower010 showed a disease-free survival benefit with atezolizumab versus best supportive care after adjuvant chemotherapy in patients with resected stage II–IIIA NSCLC, with pronounced...

View the latest program sessions on the International Waldenstrom’s Macroglobulinemia Foundation’s Live Events...